<DOC>
	<DOCNO>NCT02140853</DOCNO>
	<brief_summary>Objective 1 . To evaluate impact MDR pathogen prognosis therapy cost ; 2 . To compare efficacy different antibiotic treatment infection cause MDR pathogen ; 3 . To evaluate risk factor MDR pathogens infection ; 4 . To evaluate distribution characteristic MDR pathogens ; 5 . To investigate proportion MDR isolate construct systematic database .</brief_summary>
	<brief_title>MDR Bacilli Surveillance Clinical Feature China</brief_title>
	<detailed_description>1 . Background : In recent year , incidence infection cause multi-drug resistant ( MDR ) pathogen keep increase . The increase MDR bacterial serious challenge empirical therapy . Common empirical antibiotic may cover MDR pathogen inappropriate patient infection cause MDR pathogen , finally increase mortality . A number study demonstrate MDR pathogen related excess mortality , long hospital stay treatment cost . Compared infection cause non-MDR pathogen , infection cause MDR pathogen possess high mortality 10 % 15 % , long ICU stay 6 -10 day , less appropriate empirical antibiotic 50 % . In addition , study show treatment infection cause MDR pathogen expensive $ 10,000- $ 50,000 sensitive pathogen . Monitoring MDR pathogen may find epidemiological trend , discover new MDR bacteria , evaluate risk factor assess effectiveness intervention . Data MDR pathogens available Europe United States , however , absent China . By , feature bacterial resistance different region , hospital , certain patient exposure antibiotic , still keep uncertainty . The current study enroll continuous MDR isolate clinical data patient pathogen isolate . The data may clarify distribution characteristic MDR pathogens China , well clinical outcome infection cause MDR pathogen , essential management treatment infection cause MDR pathogen . 2 . Study center : 10 3 . Strains MDR gram-negative bacillus isolate low respiratory tract , pleural effusion blood report clinician . Confirmation isolate 'real ' pathogen certain infection , colonization pollution , need . Microbiologic data collect , result susceptibility test . Inclusion criterion : 1 . Gram-negative bacillus . 2 . Resistant 3 kind antibacterial agent . Exclusion criterion : 1 . Repetitive organism isolate center one patient . 2 . Judged colonization pollution clinician . 3 . Enrolled trial , data available current study . 4 . Microbiologic investigator collect data : 1 . General data , strain name , source department . 2 . Result susceptibility test . 5 . Clinical data : The current trial observational . Clinicians , rather investigator , decide therapy . Clinical investigator confirm MDR organism pollution colonization definition nosocomial infection result semi-quantitative culture . For eligible strain , correspond clinical data collect . 1 . Demographic data . Name , gender , age date admission . 2 . Symptoms sign , especially related infection . 3 . Laboratory result , blood urine routine , biochemistry . 4 . Medical complication , especially influence immunity , diabetes , hepatic cirrhosis , malnutrition , malignancy , HIV infection transplantation . 5 . Previous medical therapy , especially late usage antibiotic , steroid immunosuppressive agent . 6 . Management infection , include regimen duration antibiotic therapy , prognosis , treatment total cost . 7 . Outcome treatment , include efficacy end antibiotic therapy 30-day , ICU stay time , total hospital stay , cost antibiotic totaltherapy cost . 6 . Sample size : Continuous MDR gram-negative bacillus clinical data : 1500 case . Continuous Non-MDR gram-negative bacillus clinical data : 1500 case . 7 . Endpoint : 1 . Mortality therapy cost MDR non-MDR infection . 2 . Success rate different antibiotic regimen treatment MDR infection . ( Classified 3rd 4th cephalosporin , β-lactam β-lactamase inhibitor compound , carbapenems others , monotherapy combine therapy ) 3 . Risk factor infection cause MDR pathogen . 4 . Resistant profile MDR bacillus responsible infection . 5 . Therapy cost MDR non-MDR infection . 8 . Statistical analysis : Statistical analysis conduct t-test continuous variable chi-square test categorical variable . Multivariate regression analysis , Logistic regression model use clarify independent risk factor infection death . All p value retain decimal point two , statistical significance set p &lt; 0.05 .</detailed_description>
	<criteria>1 . Gramnegative bacillus . 2 . Resistant 3 kind antibacterial agent . 1 . Repetitive organism isolate center one patient . 2 . Judged colonization pollution clinician . 3 . Enrolled trial , data available current study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>MDR gram-negative bacillus</keyword>
	<keyword>Mortality</keyword>
	<keyword>Therapy</keyword>
</DOC>